Skip to content
Clinical Trials – home

City Clinic Research Sp. z o.o.

Verified siteinfo

Poland Ul. Popularna 62a, 02-473 Warsaw, Poland

  • 3 trials recruiting
  • Amyotrophic lateral sclerosis · Migraine
  • Adult patients

About Specializations

City Clinic Research Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as Amyotrophic lateral sclerosis, Migraine, and other specialisations. This site conducts important research.

Main research areas of the site

Amyotrophic Lateral Sclerosis (ALS) Research

The medical center is at the forefront of research into Amyotrophic Lateral Sclerosis, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The institution is dedicated to exploring innovative therapeutic approaches to improve patient outcomes and quality of life.

  • Development of novel therapeutic agents
  • Comprehensive safety assessments
  • Advanced efficacy evaluations

Through rigorous clinical trials, the center is pioneering the use of dazucorilant as a potential treatment, focusing on both its efficacy and safety in patients with ALS. This research is contributing significantly to the understanding and management of this challenging condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Popularna 62a02-473 WarsawPoland
Recruiting now
3 trials
Conditions studied
2
Partner status
Verified site

More sites in WarsawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole

A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Ferrer Internacional S.A.

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazucorilant
  • Sponsor:Corcept Therapeutics Inc.

Migraine

Not recruiting

Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation

Study on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG

Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Phenylbutyrate
  • Sponsor:Amylyx Pharmaceuticals Inc.

Study of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Cromoglicate
  • Sponsor:Phenonet Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.